| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Thursday, March 31, 2022 2:30:45 PM
And that, my anonymous fellow traveller, is exactly the point....its a "war" of attrition to see who survives this slow agonizing grind.
Mike could or maybe should have hyped this trial up like every single other Ceo in the therapeutic space but for some unknown reason he didnt....maybe he doesnt like $$$$???
Fact is for the stage Revive is at this continuous drop makes little sense since they are literally at the cusp of filing for an EUA.
All clears from the dsmb to modify the trial parameters with zero safety issues to date and still this shite???
Me thinks something be afoot here laddies!
Short of bad news being leaked, dont think so, whats happening goes totally against the norm for the position Revive is currently in.
Jus sayin....but wth do i know.
Mike could or maybe should have hyped this trial up like every single other Ceo in the therapeutic space but for some unknown reason he didnt....maybe he doesnt like $$$$???
Fact is for the stage Revive is at this continuous drop makes little sense since they are literally at the cusp of filing for an EUA.
All clears from the dsmb to modify the trial parameters with zero safety issues to date and still this shite???
Me thinks something be afoot here laddies!
Short of bad news being leaked, dont think so, whats happening goes totally against the norm for the position Revive is currently in.
Jus sayin....but wth do i know.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
